Lotus Pharm vs Level Biotechnology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Level Biotechnology (3118) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Level Biotechnology

0%+226%-49%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYLevel BiotechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$46.3 million-8.2%
Sep 2026NT$2.77 billion+128.0%NT$63.7 million-9.2%
Aug 2026NT$2.11 billion+81.7%NT$56.8 million-16.2%
Jul 2026NT$2.49 billion+3.9%NT$65.5 million+5.5%
Jun 2026NT$3.4 billion+225.5%NT$54.7 million-3.6%
May 2026NT$2.32 billion+105.8%NT$49.4 million-9.1%
Apr 2026NT$3.09 billion+19.9%NT$58.2 million-3.6%
Mar 2026NT$4.35 billion+173.6%NT$70.3 million+0.7%
Feb 2026NT$2.24 billion+131.5%NT$31.3 million-48.6%
Jan 2026NT$2.05 billion-5.5%NT$57.2 million+24.2%
Dec 2025NT$2.44 billion+66.9%NT$78.7 million+8.7%
Nov 2025NT$1.06 billion-0.2%NT$58.9 million-12.0%
Oct 2025NT$2.75 billion+46.0%NT$50.4 million-22.9%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16